A C3 blood test measures how much complement component 3 is circulating in your blood, and it is one of the quickest ways a clinician can tell whether your immune system is currently working overtime. C3 is a protein made mostly in the liver that helps antibodies and immune cells find and clear bacteria, viruses, and damaged cells. When that clearance process runs hot for a long time, C3 gets used up and blood levels fall; when the body is fighting a short-lived infection or a flare of inflammation, levels often rise instead. In this article you will learn what the test measures, what the normal range looks like, why doctors usually order C3 alongside C4, what high and low results can point to, and how researchers are now using the same protein to guide new kidney treatments.
What the C3 blood test measures
Complement component 3 sits at the center of the complement system, a group of roughly 30 blood proteins that act as a rapid-response layer of immunity. C3 is the busiest of them: nearly every route through the complement cascade converges on it. When C3 is split into two fragments, one piece coats the surface of a microbe so immune cells can grab it, and the other calls white blood cells toward the site.
The test itself is a simple measurement of concentration, usually reported in milligrams per deciliter. It does not tell you whether your complement proteins are working correctly, only how much C3 is present at the moment blood was drawn. That distinction matters. A person can have a normal C3 concentration and still have a complement system that is behaving abnormally, which is why clinicians read the number alongside symptoms and other markers.
Because C3 is a plasma protein made in the liver, it also moves with general protein production and nutritional status. Reviewing your overall total protein blood test results gives useful background when a single protein looks unexpectedly low, since widespread protein loss or reduced liver synthesis affects many values at once rather than C3 alone.
Why a doctor orders a C3 blood test
Clinicians rarely order C3 as part of a routine checkup. It appears when there is a specific question about immune activity, and the most common reasons fall into four groups.
- Suspected or confirmed autoimmune disease, especially systemic lupus erythematosus, where falling complement often tracks with a flare.
- Unexplained kidney findings such as protein or blood in the urine, swelling, or a rising creatinine that suggests glomerular inflammation.
- Recurrent bacterial infections in a child or adult, which can point to an inherited complement deficiency.
- Monitoring an existing diagnosis, to see whether treatment is calming the immune activity that was consuming complement.
In an autoimmune workup, C3 almost never travels alone. A clinician typically pairs it with an antibody screen, and understanding what an antinuclear antibody test detects explains why: antibodies identify the immune attack, while complement levels show how much fuel that attack is burning. In joint-focused evaluations, doctors may add a rheumatoid factor blood test to separate one inflammatory arthritis pattern from another.
C3 blood test normal range and how to read your report
Reference ranges differ between laboratories because they use different instruments and calibrators. Mayo Clinic Laboratories reports an adult reference value of 75 to 175 mg/dL, while Cleveland Clinic describes a typical normal range of roughly 80 to 178 mg/dL. Always compare your number to the range printed on your own report rather than to a range you found online.
The table below shows how C3 results are usually grouped and what each band tends to prompt in practice.
| Result band | What it usually reflects | Common next step |
|---|---|---|
| Below the lab reference range | Complement is being consumed faster than the liver replaces it, or production is reduced | Autoimmune and kidney workup, C4 comparison, repeat testing over time |
| Within the lab reference range | No current evidence of heavy complement consumption | Interpreted with symptoms and other markers; may be repeated if symptoms persist |
| Above the lab reference range | An acute-phase response to infection, injury, or ongoing inflammation | Look for the inflammatory source; recheck once the acute episode resolves |
| Rising after a low result | Immune activity that was consuming complement is settling down | Often read as a favorable response to treatment |
If the layout of your report is unfamiliar, this guide to reference ranges, flags, and next steps for lab results explains how the columns fit together before you focus on any single value.
What high and low C3 results can mean
C3 moves in both directions, and the direction carries most of the information. The pattern over several tests usually tells a clearer story than any single reading.
Low C3 levels
A low C3 usually means the complement system has been activated hard enough to deplete the protein. According to MedlinePlus, decreased complement is associated with lupus, rheumatoid arthritis, certain kidney diseases, cirrhosis, hereditary angioedema, malnutrition, and recurring bacterial infections. Mayo Clinic Laboratories adds acute glomerulonephritis, membranoproliferative glomerulonephritis, immune complex disease, septic shock, and end-stage liver disease to that list.
In practice the two big categories are autoimmune disease and kidney disease. In lupus, immune complexes deposit in tissue and consume complement as they are cleared, so a drop in C3 frequently accompanies a flare. Reading about the symptoms and treatment options for lupus helps put a low complement result into context, because the number alone never establishes a diagnosis. When the kidney is involved, clinicians look for protein leaking into the urine and check kidney filtering capacity, which is why a low C3 often arrives alongside a creatinine blood test result and a urine study measuring protein in a urine sample.
Persistently low C3 with declining kidney function raises the possibility of a complement-driven kidney disease, and clinicians then consider whether the picture fits chronic kidney disease and its causes or a rarer complement-specific condition confirmed by biopsy.
High C3 levels
A high C3 is less specific and usually less worrying. C3 behaves as an acute-phase protein, meaning the liver produces more of it during infection, injury, or inflammation. Cleveland Clinic notes that elevated C3 typically reflects an immune response to a recent infection, and that in someone being treated for autoimmune disease a rising level often signals that treatment is working. Elevated values have also been described with sarcoidosis, thyroid disease, ulcerative colitis, some cancers, and cardiovascular disease.
Because the same trigger raises several inflammatory markers at once, a raised C3 is often accompanied by a raised C-reactive protein blood level. If your clinician is looking for lower-grade, longer-running inflammation rather than an acute episode, a high-sensitivity version of that test is usually the one ordered, since it detects smaller changes than the standard assay.
Reading C3 and C4 together: the pattern that matters
Complement proteins are rarely measured alone. C3 sits where two activation routes meet, and C4 sits only on the classical route, so comparing them tells a clinician which pathway is being used. Understanding what a C4 complement blood test measures makes the combination far easier to read.
| C3 | C4 | Typical interpretation |
|---|---|---|
| Low | Low | Classical pathway activation, the pattern most often seen in an active lupus flare or immune complex disease |
| Low | Normal | Alternative pathway activation, which points toward complement-driven kidney conditions and prompts specialist review |
| Normal | Low | Often an inherited C4 variation or hereditary angioedema rather than active consumption |
| High | High | A general acute-phase response; both proteins rise together with inflammation and usually settle afterward |
This is the single most useful habit when reading a complement panel: look at the pair, then look at the trend. A one-time low C3 with a normal C4 in someone with no symptoms means something very different from the same result in someone with swelling, fatigue, and protein in the urine.
What happens before, during, and after the test
The C3 blood test needs no special preparation in most cases. Cleveland Clinic states that no fasting or advance steps are required, though your own clinician may ask you to fast if other tests are being drawn at the same time. Tell the laboratory about any medication you take, including corticosteroids and immune-suppressing drugs, since treatment can shift complement levels.
The draw itself takes a few minutes. A technician cleans a spot on your arm, inserts a needle into a vein, collects a tube of blood, and applies a bandage. Most people feel a brief sting. Bruising at the site is the most common after-effect and usually fades within a few days.
Results are typically available within a few days. One practical point is worth knowing: complement proteins are fragile, and samples that sit at room temperature too long can show falsely low values. If a single low result does not match how you feel or what other tests show, ask whether repeating it is reasonable before drawing conclusions.
When to see a doctor about your results
Any abnormal C3 result deserves a conversation with the clinician who ordered it, but a few situations warrant prompter attention.
- Swelling in the legs, ankles, or around the eyes, or urine that looks foamy, tea-colored, or pink, alongside a low C3.
- A lupus diagnosis with a falling complement level plus new joint pain, rash, fever, or fatigue, which may indicate a flare.
- Repeated serious bacterial infections, particularly meningococcal infections, in someone with a persistently low complement level.
- A low C3 that stays low across several tests without an explanation, which usually calls for specialist review by a rheumatologist or nephrologist.
Blood in the urine is a frequent companion of complement-driven kidney inflammation, and this guide to blood in the urine and what causes it covers how that finding is investigated.
Latest scientific advances
Complement research has moved quickly over the past three years, and much of it centers on C3 itself. Here is what the recent literature indexed in PubMed shows, in plain terms.
The first shift is conceptual. An international kidney panel convened by KDIGO, an organization that writes global kidney guidelines, reviewed the evidence in 2024 and concluded that complement activation contributes to many more kidney diseases than the two rare conditions it was classically tied to, including diabetic kidney disease and several forms of glomerulonephritis. What this means for you: a low complement result is being taken seriously in a wider set of kidney situations than it was a decade ago, and a nephrologist may investigate it even when your diagnosis is a common one.
The second is a genuine treatment result. A phase 3 trial published in The Lancet in 2025 tested iptacopan, an oral drug that blocks the alternative complement pathway, in adults with C3 glomerulopathy, a rare kidney disease named after the protein. Over six months, people taking the drug had roughly a third less protein leaking into their urine than people taking a placebo, and the drug was well tolerated. Protein loss in urine is a standard measure of how much damage a kidney filter is sustaining, so a reduction of that size is meaningful rather than cosmetic. What this means for you: for a disease that had no targeted therapy, there is now trial evidence that a complement-blocking pill changes a hard outcome measure, although long-term kidney survival data are still being collected.
The third concerns how well C3 performs as a monitoring tool. A 2025 evidence review of lupus nephritis biomarkers, meaning kidney involvement in lupus, compared dozens of newer candidate markers against the traditional ones. Its conclusion was blunt: despite a decade of intensive research, no newer marker has replaced the classics, and serum C3, anti-dsDNA antibodies, and urine protein remain the tools with the strongest clinical evidence for tracking disease activity and predicting flares. What this means for you: if your care team keeps rechecking C3, that is current best practice rather than an outdated habit.
The fourth is mechanistic and still preliminary. A 2025 laboratory study examined why some people dysregulate complement more than others, showing that the balance between factor H, a brake on the system, and a related protein called FHR-1 shifts as kidney function declines, which in turn increases complement activity. This was laboratory and cohort work rather than a treatment trial, so it needs confirmation. What this means for you: it helps explain why complement problems and worsening kidney function tend to reinforce each other, and it points to where the next generation of tests may be aimed.
Across all four, the practical takeaway is the same. C3 remains a useful, inexpensive signal of immune activity, its value comes from repeated measurement rather than a single snapshot, and the therapies built around it are advancing faster than the tests themselves. It measures antibody-driven immune activity from a different angle than an immunoglobulin G blood test, which is one reason both often appear in the same immune workup.
Glossary of key terms
| Term | Definition |
|---|---|
| Complement system | A group of about 30 blood proteins that work with antibodies and immune cells to destroy microbes and clear damaged cells. |
| Complement component 3 (C3) | The most abundant complement protein, made mainly in the liver, where all activation routes converge. |
| Classical pathway | The complement route triggered by antibodies bound to a target. It consumes both C3 and C4. |
| Alternative pathway | A complement route that switches on without antibodies. It consumes C3 while leaving C4 largely untouched. |
| Acute-phase protein | A protein the liver produces in larger amounts during inflammation, infection, or injury. |
| Immune complex | A clump of antibody bound to its target that can lodge in tissue and trigger complement activation. |
| Glomerulonephritis | Inflammation of the kidney’s filtering units, which can allow protein and blood to escape into urine. |
| Systemic lupus erythematosus (SLE) | An autoimmune disease in which the immune system attacks the body’s own tissues, often consuming complement during flares. |
| Proteinuria | Protein leaking into the urine, a standard sign that kidney filters are damaged or inflamed. |
| Reference range | The span of values a laboratory considers typical for a healthy population using its own equipment. |
Frequently asked questions
What causes high C3 and C4 complement levels at the same time?
When both proteins rise together, the usual explanation is an acute-phase response. The liver increases production of many proteins during infection, tissue injury, surgery, or a period of active inflammation, and complement proteins are among them. Chronic inflammatory conditions, some cancers, and inflammatory bowel disease have also been linked to raised complement levels. On its own, a modestly high C3 and C4 pattern is not considered a specific diagnostic finding, and clinicians generally look for the underlying inflammatory trigger rather than treating the numbers. Rechecking after the acute episode passes usually shows the values returning to baseline.
What causes low C3 and C4 complement levels together?
The combination of low C3 and low C4 points to the classical complement pathway being heavily activated, which most often happens when antibodies form immune complexes that get cleared in large numbers. Active systemic lupus erythematosus is the textbook cause, particularly when the kidneys are involved. Other possibilities include certain infections, immune complex kidney disease, severe liver disease that reduces protein production, and rare inherited deficiencies. Your clinician will read the pattern alongside your symptoms and antibody tests, because the same laboratory pattern can arise from very different situations.
What is the normal range for a C3 blood test?
Published adult reference values sit broadly between 75 and 178 mg/dL, with Mayo Clinic Laboratories using 75 to 175 mg/dL and Cleveland Clinic describing roughly 80 to 178 mg/dL. The exact numbers depend on the analyzer and calibrator each laboratory uses, so the range printed on your own report is the one that applies to you. Ranges can also vary somewhat with age and sex. If you are tracking C3 over time, using the same laboratory for each draw makes the comparison far more reliable than mixing results from different sources.
Can a low C3 result be normal for me?
It can. A small number of people carry an inherited complement deficiency and run a persistently low level without active disease, and laboratory handling problems can also produce a falsely low value if a sample warms up before processing. That said, an unexplained low C3 is not something to dismiss on your own. The usual approach is to repeat the test, compare it with C4, and check kidney and autoimmune markers. If everything else is normal and you have no symptoms, your clinician may simply monitor the value periodically.
Do I need to fast before a C3 blood test?
Generally no. Cleveland Clinic states that the C3 complement blood test requires no special preparation. You may still be asked to fast if the C3 is drawn as part of a wider panel that includes tests such as glucose or a lipid profile. It is worth mentioning any medication you take, especially corticosteroids or immune-suppressing therapy, because these can influence complement levels and help your clinician interpret the result correctly.
How often should C3 be rechecked?
There is no single schedule. In someone with active lupus or a complement-mediated kidney disease, complement levels are often rechecked every few months, or more frequently around a flare or a treatment change, because the trend guides decisions. In someone whose result was borderline and who has no symptoms, a single recheck after several weeks may be all that is needed. Your clinician sets the interval based on your diagnosis, your treatment, and how the previous results have moved.
Sources
- MedlinePlus, National Library of Medicine — Complement Blood Test — MedlinePlus Medical Test, updated 2024 — medlineplus.gov
- Cleveland Clinic — C3 Complement Blood Test: What It Is, Procedure and Results — Cleveland Clinic Health Library, 2022 — my.clevelandclinic.org
- Mayo Clinic Laboratories — Complement C3, Serum — Mayo Clinic Laboratories Test Catalog, 2025 — mayocliniclabs.com
- Vivarelli M, Barratt J, Beck LH, et al. — The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference — Kidney International, 2024 — doi.org/10.1016/j.kint.2024.05.015
- Kavanagh D, Bomback AS, Vivarelli M, et al. — Oral iptacopan therapy in patients with C3 glomerulopathy: a randomised, double-blind, parallel group, multicentre, placebo-controlled, phase 3 study — The Lancet, 2025 — doi.org/10.1016/S0140-6736(25)01148-1
- Vrabie A, Obrisca B, Sorohan BM, Ismail G — Biomarkers in Lupus Nephritis: An Evidence-Based Comprehensive Review — Life, 2025 — doi.org/10.3390/life15101497
- Slagle AK, Ghiringhelli Borsa N, Wang K, et al. — Factor H-related 1 and heparan sulfate architecture contribute to complement dysregulation in C3 glomerulopathy — Frontiers in Immunology, 2025 — doi.org/10.3389/fimmu.2025.1589674
Further reading
- Compare the two complement proteins side by side by reading our C4 complement blood test guide.
- Check how early kidney damage is detected in urine with this guide to the albumin to creatinine ratio and what it shows.
- Explore the antibody fraction that complement works alongside in this guide to gamma globulin levels and their meaning.
- Review the inflammatory joint disease often screened at the same time in our rheumatoid arthritis symptoms and treatment guide.
- Understand how the blood protein that carries most of your plasma volume is assessed in this guide to albumin blood test results.
Understand your lab results with BloodSense
A C3 value carries most of its meaning in company: next to C4, next to kidney markers, and next to your own previous results. Reading one complement number in isolation is how a routine fluctuation gets mistaken for a problem, and how a meaningful downward trend gets missed. BloodSense turns a full report into plain language, showing where complement, kidney markers such as creatinine and urine protein, and inflammatory markers sit relative to their reference ranges, and how they have moved between draws. It helps you understand what you are looking at and prepare better questions for your clinician; it does not diagnose and it does not replace medical care.
